PB2154: TP53 GENE MUTATION DIVERSITY IN RUSSIAN PATIENTS WITH B-CELL LYMPHOMAS

por Biderman, B., Severina, N., Koroleva, D., Gabeeva, N., Belyaeva, A., Tatarnikova, S., Babaeva, F., Nesterova, E., Mangasarova, Y., Margolin, O., Bagova, M., Magomedova, A., Kravchenko, S., Obukhova, T., Zvonkov, E., Sudarikov, A.
Publicado 2022

PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.

por Sychevskaya, K., Kravchenko, S., Babaeva, F., Misyurina, A., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Fastova, E., Gorenkova, L., Nesterova, E., Mangasarova, Y., Bagova, M., Margolin, O., Magomedova, A.
Publicado 2022

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.

por Mangasarova, Ya.K., Moiseeva, T.N., Al-Radi, L.S., Margolin, O.V., Gorenkova, L.G., Nesterova, E.S., Bagova, M.O., Fastova, E.A., Abdurashidova, R.R., Sarakaeva, Z.T., Dorokhina, Elena, Kravchenko, S.K., Magomedova, A.U., Zvonkov, E.E.
Publicado 2022

P1207: MULTICENTER RANDOMIZED CONTROLLED (COMPARATIVE) OPEN PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF THE R-DA-EPOCH-21 AND R-MNHL-BFM-90 ± AUTO- HSCT PROGRAMS IN PATIENTS WITH...

por Magomedova, A., Kravchenko, S., Misyurina, A., Mangasarova, Y., Margolin, O., Fastova, E., Babaeva, F., Gorenkova, L., Bagova, M., Nesterova, E., Sychevskaya, K., Moiseeva, T., Kovrigina, A., Obukhova, T., Dvirnyk, V., Galtseva, I., Galuzyak, V., Maryina, S., Danishyan, K., Kostina, I., Sudarikov, A., Klyasova, G., Kulikov, S., Chabaeva, Y., Zinina, E., Kryuchkova, I., Sizikova, S., Sergeyevicheva, V., Ksenzova, T., Anikina, E., Shelekhova, T., Arzhanukhina, O., Kaplanov, K., Konstantinova, T., Serdyuk, O., Sychyova, T., Chagorova, T., Nechunayeva, I., Anchukova, L., Dzarasova, O., Parovichnikova, E., Savchenko, V.
Publicado 2022